← Previous Lesson Lesson Evaluation: The Rheumatology Biosimilar Landscape in 2022 Name* First Last Email* HiddenState State HiddenPlace of Employment:* Professional Title* Nurse Nurse Practitioner Physician Physician Assistant Pharmacist Other if you selected "other", please specify.* Specialty* Rheumatology Dermatology Other if you selected "other", please specify.* This activity improved my: (check all that apply) Knowledge Competence/Skills Performance Patient Outcomes None of the above Content was useful and relevant to my practice*Strongly disagreeDisagreeNeutralAgreeStrongly agreeThe activity was fair, balanced, and free of commercial bias*Strongly disagreeDisagreeNeutralAgreeStrongly agreeI am better able to: Explain key concepts related to biosimilars such as drug interchangeability, substitution, and data extrapolation*Strongly disagreeDisagreeNeutralAgreeStrongly agreeI am better able to: Analyze current barriers to the use of biosimilars in clinical practice*Strongly disagreeDisagreeNeutralAgreeStrongly agreeI am better able to: Discuss the importance of patient education surrounding biosimilars and the appropriate role of the nurse and advanced practice provider as patient educator as part of the shared decision making process*Strongly disagreeDisagreeNeutralAgreeStrongly agreeI would recommend this activity to others*Strongly disagreeDisagreeNeutralAgreeStrongly agreeBased on what you learned in this activity, what will you do differently in the care of your patients? (check all that apply)**check all that apply Implement new information or skill in my practice Create/revise protocols, policies, and/or procedures Seek additional information Activity validated current practice Do nothing differently—The content was not convincing Do nothing differently—System barriers prevent me from changing my practice Not applicable. I have no patient contact Please write a short statement about what you will do differently in your practice because of what you learned (if no change, write “N/A”)* Quizzes Status Post Test: The Rheumatology Biosimilar Landscape in 2022
